Randox scientists showcase our home-grown healthcare innovation at the world’s largest medical exhibition
Randox Laboratories is representing our ever-growing knowledge economy this week at the world’s largest medical exhibition, the Medica World Forum for Medicine International Trade Fair.
Randox is joining a host of other healthcare exhibitors from over 120 countries, on over 1.3million square feet of exhibition space at the Düsseldorf Fairgrounds in Germany. The event, which runs for four days between Monday and Thursday, will showcase the latest developments across a range of medical sectors including Laboratory Equipment, Diagnostics, Physiotherapy and Orthopedic Technology, Communication and Information Technology, and Medical Services and Publications.
The Medica Trade Fair provides Randox and over 4800 other exhibitors the opportunity to showcase new and existing diagnostic capabilities to the world. With key manufacturing sites in Co. Antrim and Co. Donegal, in India and just outside Washington DC, Randox Laboratories diagnostics are already used and trusted by medical professionals across the globe, and are also available to the general public at Randox Health Clinics in Northern Ireland and in London.
Exporting to 145 countries, and with more tests in development than any other diagnostics company, Randox is a leading innovator in the fight against illnesses such as cancer, coronary heart disease and diabetes, and is dedicated to saving and improving lives around the globe through preventative healthcare and early diagnosis.
At the Medica Fair, 30 members of the Randox team, including Senior Managers and Expert Scientists from a range of disciplines, will showcase to over 130,000 visitors a range of novel diagnostic tests for conditions such as diabetes, aspirin resistance, cardiovascular risk and gastric problems – highlighting just how our home-grown scientists are benefiting lives across the globe.
John Lamont, Chief Scientist at Randox Laboratories, commented:
“As a firmly established event in the medical calendar, The Medica Fair is the perfect opportunity for Randox to display to the global healthcare industry how our world-class diagnostics make a difference in the lives of so many patients across the world. From routine cholesterol checks to complex tests used in diagnosis of respiratory conditions, Randox is working behind the scenes from the moment you provide a blood sample to your GP.
In addition to our range of current extensive capabilities, we are also excited to share some new tests for aspirin resistance, cardiovascular risk and gastric problems at the Medica Fair, the hub of the medical trade. Randox is at the forefront of life-changing research and development in the medical industry and we are proud that we can show the Medica audience how our innovative diagnostic tests are paving the way for the future of healthcare.”
The Medica World Forum for Medicine International Trade Fair runs from Monday 16th to Thursday 19th November, and Randox will be in Hall 3 at Stand A08.
Donegal will be promoted as a world-class place to live and do business, at a leading Irish-American event in Boston this week.
The annual conference of Irish Networks USA, which connects Irish associations in cities across the US in order to bolster business, cultural, and community links between the United States and Ireland, is taking place between 5th and 8th November.
Irish and Irish-American professionals living across the US will attend the event, to engage with the Irish diaspora and with key envoys from Irish businesses. Supported by the Department of Foreign Affairs and Trade of Ireland, those attending will have the opportunity to hear from speakers including the Irish Ambassador to the United States, Anne Anderson, and Mark Redmond, Chief Executive of the American Chamber of Commerce Ireland.
Additional backing for the event comes from Tourism Ireland and leading Donegal-based company, Randox Laboratories, which boasts facilities in Dungloe, as well as Co. Antrim and the Greater Washington DC area. Through reaching out to the Irish diaspora in the US, the company plans to promote the growing economy in Donegal through the creation of hundreds of new jobs over the next few years, as well as promote opportunities at the US facility near Washington DC.
The event kicks off on Thursday evening with a welcome gathering for those who have travelled to Boston from across the US, before the conference begins on Friday 6th November, where attendees will engage on a range of topics including global education, transatlantic business links, and the global Irish diaspora network. Delegates are then invited to celebrate the fifth anniversary of Irish Network Boston at the historic venue of Massachusetts Old State House.
Mark Campbell, Senior Manager at Randox Laboratories, is speaking at the conference:
“We are delighted to promote Donegal as a world-class destination for life-science professionals. Working with the diaspora network, we can get the message out there that Donegal has exciting career opportunities, great community networks and strong infrastructure, proving it to be a highly desirable place to work and live.
Additionally, as Randox expands its operations in the US, we are keen to promote our facility in the Greater Washington DC area where there will be increasing job opportunities over the next few months.”
Are you The One for Randox?
That’s the question Randox Careers are asking first year students this week, with the launch of an innovative new recruitment campaign for their competitive APEX Programme, which employs first year undergraduates across various divisions of the global diagnostics company.
The campaign, named #IAmTheOneUU, which begins this week with a number of recruitment presentations in Ulster University, is taking a fresh approach to the way first years can apply for the APEX Programme, by inviting applicants to submit ‘video auditions’ on social media platforms Facebook, Instagram and Twitter. Using a video no longer than 15 seconds and a 140 character cover note, the aim of this unique method of application is to give first year university students the opportunity to succinctly and effectively convey their personality, creativity, initiative and drive, in a lively and imaginative way; displaying why they are ‘The One’ for Randox.
Successful APEX applicants from Ulster University will progress throughout Randox over the course of four years; moving from a summer of paid full-time work experience, to a paid placement year within the company, to ultimately obtaining a full time position at Randox, subject to gaining a 2:1 or above.
The importance of this opportunity cannot be underestimated; with many students having difficulty finding jobs after graduation, the APEX Programme will help 50+ students this year really get their foot on the career ladder, and build relationships with a thriving market leader in the healthcare industry.
Linda Magee, Randox Human Resources Manager, is excited to launch such a novel campaign that resonates so well with first year students;
“The #IAmTheOneUU application process for the Randox APEX Programme is a fresh and dynamic campaign that utilizes the power of social media and harnesses the skills of the tech-savvy generation. Young people of this age are well-acquainted with the likes of Facebook, Twitter and Instagram and by using their social media capabilities to display their personality and ambition, they can successfully achieve their career goals in positions ranging from Business and Marketing to Biological and Life Sciences, Graphic Design to Mathematics and Physics, and Engineering to Computer Technology. For busy first years this exciting yet simple method of application is the perfect way for them to introduce themselves to Randox. Get posting – you could be The One!”
Any first year undergraduates at Ulster University who wish to join the Randox APEX Programme should upload a 15 second video with accompanying 140 character note to either Twitter, Facebook or Instagram, making sure to include the hashtag #IAmTheOneUU.
Visit Iamtheone.randox.com for more information.
As global sponsor of Camerata Ireland, Randox will be taking to the world’s stage with the all-Ireland orchestra in South America this week, as the Chamber Orchestra begins their South American tour tonight in Buenos Aires.
World-renowned pianist and conductor Barry Douglas and his orchestra of talented musicians, whose joint patrons are Michael D Higgins, President of Ireland and Queen Elizabeth II, have made the long journey from Ireland to Argentina for tonight’s performance, to display the rich Irish musical heritage to South American audiences.
The tour, which begins this evening in the renowned Teatro Coliseo in Buenos Aires will see the all-Ireland orchestra perform a diverse tapestry of classical music, led by Camerata Ireland founder and 1986 Tchaikovsky International Piano Competition Winner Barry Douglas, and supported by distinguished flautist Eimear McGeown, who has established a busy and varied musical career since winning Camerata Young Musician of the Year in 2006.
Tomorrow night the orchestra will remain in Argentina for a performance at the Teatro El Círculo Laprida in Rosario and on Friday night will capture the audience of the Teatro del Libertador in Córdoba, and finally head to Santiago de Chile for the final installment of their South American tour in the Teatro CorpArtes. Barry and Eimear are also performing at a special event at the British Consulate in São Paulo in Brazil.
Barry Douglas, Creator and Artistic Director of Camerata Ireland said;
“We are all thrilled to be here in South America for our tour across the continent – there is nothing quite like music in its ability to connect with cultures across the globe. Music as a universal language can be understood and appreciated by anyone, and we are excited to be able to convey an image of Ireland to audiences across South America, through our performances. We are equally delighted that we can share this experience with Randox Laboratories, who continue to help the growth and development of our orchestra, and we couldn’t have achieved our internationally-acclaimed reputation without them.”
Dr. Peter FitzGerald, Managing Director at Randox Laboratories said;
“It is not surprising that at Randox we truly value our partnership with Camerata Ireland, given that both organisations rely on the same values of passion and enthusiasm for their international success. On behalf of everyone here at Randox I would like to wish Camerata Ireland all the best with their South America tour. We are delighted that Barry Douglas and his orchestra continue to showcase our Irish musical talent across the globe, and it brings us great joy knowing that Randox can simultaneously support our young Irish musicians in their careers while also strengthening key business relationships and promoting exports.”
Camerata Ireland will perform tonight the 21st October in Buenos Aires, in Rosario on the 22nd October, in Cordoba the 23rd October, at The British Consulate in São Paulo on the 28th, and will also perform two events in Santiago de Chile on the 29th and 30th October.
Representatives from business, community and political life in northwest Ireland travelled to Boston this week to take part in the seventh annual Golden Bridges conference promoting transatlantic partnerships.
Among key Irish American speakers at the two day gathering (21-22 October 2015) are Mayor Marty Walsh of Boston and Marty Meehan, President of the University of Massachusetts.
Backed by Councils from Donegal, Derry City, and Strabane, the event in the Seaport Hotel, Boston, will hear from Donegal County Council Chairperson, Councillor Ciarán Brogan, and Maiden City Mayor, Councillor Elisha McCallion.
Key backing for the transatlantic initiative has come from Invest Northern Ireland in the US with two companies which have made recent investments in Derry-Londonderry, OVS and Metaverse Mod Squad, being honoured at a gala luncheon during the conference.
The event in Boston will focus on a life sciences forum on linking Boston and North West Ireland’s changing life sciences industries. Speakers will include bio-entrepreneur Susan Whoriskey and Mark Campbell, Senior Manager at Randox Laboratories which boasts facilities in Co. Antrim, Co. Donegal and in the US. Mark will also be speaking at Harvard University on the potential of Irish life science innovations to improve healthcare globally. Commenting on the event, Mark said:
“This is a great opportunity to strengthen life science links between the North West of Ireland and Boston. We at Randox know that we have much to offer and we’re very grateful for the support from Donegal County Council and Údarás na Gaeltachta in enabling this event to happen.”
For more details: aisling-events.com
Young women should be offered ‘fertility MoTs’ at 25 so that they don’t leave it too late to start a family, doctors have said.
The British Fertility Society has warned that many young women are unaware of how their ability to conceive declines with age and has called for fertility checks to be introduced by the NHS to act as a “wake up call”.
The warning is intended to highlight the risks associated with waiting too long to start a family, such as the heartache of later infertility and complications in pregnancy and child birth.
Professor Adam Balen, Chairman of the British Fertility Society is quoted in the national press as wanting to “put the family back into family planning”, and said that many women were far too optimistic about their biological clock, and that women do not have the control over their fertility that easy access to contraception has led them to believe.
Checks could indicate whether you are more likely to have problems, or start having problems, and could indicate key measures such as how many eggs a woman has left. Consultations could include diet and lifestyle advice such as stopping smoking, cutting back on alcohol and checks on obesity and anorexia, which can contribute to infertility.
The number of women in Northern Ireland aged 35-39 having babies has increased in line with current trends across the rest of the UK, with around a fifth of all babies in the UK now born to mothers over 35 as many women put off starting a family due to a pressure to develop careers. Professor Balen suggests that ideally young couples should be trying to start a family by the time they are in their late 20s, or early 30s. He said that young people need to be able to have the option of both developing careers and starting families, “not one to the exclusion of another”.
With the NHS focused on education to try to prevent pregnancy, rather than encourage it, and a cut back on providing fertility treatments for couples struggling to conceive, it has become more and more common for people to self-fund fertility tests and treatments.
Jenny Dobbs, a leading fertility expert at Randox Health Clinics suggests that a fertility test early and regularly, would help couples who are trying for a family:
“Around one in six couples in Northern Ireland have difficulty conceiving, and this is not always down to a problem with the sperm, eggs and reproductive organs. A fertility health check can be life changing for a couple who are trying for a baby, or for women who want to understand more about their current fertility levels.
Randox Health takes a unique approach to fertility through comprehensive personalised blood testing for both men and women. Highly advanced assessments, or MoTs, are designed to identify the earliest signs of illness and work with clients to prevent disease in your future, which is very important for preserving your fertility and making healthy babies.”
A ground-breaking undercover investigation has exposed the deadly world of legal highs, the latest drug craze sweeping the UK and causing devastation to families and communities across the country.
An investigative team from the BBC followed the journey of these dangerous and highly addictive substances from source to sale and used secret filming to reveal that legal substances bought in the UK’s high streets pose a hazardous and lethal risk.
During the hour-long programme this evening on BBC Scotland, journalists shine a spotlight on the growing legal high epidemic, where synthetic drugs are designed to mimic the effects of illegal drugs such as cannabis, ecstasy and cocaine.
The team enlisted the help of Randox Testing Services, to further investigate the make-up of these drugs, which contain a cocktail of chemical ingredients that suppliers continually tweak to evade the law.
But the legality of these ‘highs’ in no way makes the drugs any safer. The disturbing test results show that legal highs bought in the UK contain a poisonous mixture of synthetic cannabinoids which have as strong an effect as illegal drugs, such as LSD or Amphetamines, and in some cases even stronger.
Sadly, the statistics correspond, as Government figures show that in just three short years the number of deaths in the UK linked to legal highs grew from 12 in 2009, to 97 in 2012.
It is a growing problem that Dr. Mark Piper, Head of Toxicology at Randox Testing Services, is all too familiar with:
“It’s very much back-room and underground chemistry that’s behind all this. You don’t know what’s in them and what quantities of chemicals are used, and therefore how much to take. These substances were not even designed to be used on humans, so in taking them you are playing Russian roulette with your life.”
Piper added; “In supporting the fantastic investigative team from the BBC we are glad to assist in highlighting this growing epidemic which has had shattering effects on families and communities across the UK.”
The intense rise in prevalence of legal highs and their catastrophic effects has sparked the debate of a controversial Psychoactive Substances Bill, which potentially will implement a blanket ban on the production, distribution, sale and supply of any substance defined as having a ‘psychoactive effect’.
This BBC Scotland documentary will air tonight, Monday, 5th October 2015, on BBC One Scotland at 9p.m.
On World Heart Day 2015, Randox Laboratories unveiled a rapid, highly accurate diagnostic test to identify individuals with familial hypercholesterolemia (FH), a common disorder that is passed from parents to their children. FH is often called the ‘silent killer’ as it is characterised by dangerously high levels of cholesterol, leading to early onset cardiovascular disease. The good news is that if diagnosed, FH can be effectively treated; the even better news this National Cholesterol Month is that this new test has made diagnosis across the UK much simpler.
Thousands of families in the UK are affected by FH, as not only is heart disease the number one killer across the globe, there is a 50:50 chance that a parent with FH will pass it onto their children. The condition can lead to higher risk of a heart attack in men before the age of 50, or before the age of 60 in women.
A common disease, at least 1 in every 500 people in the UK are living with FH, although new international research suggests that 1 in every 200 people could be affected, which would mean as many as 300,000 people in the UK. Worryingly, it is substantially underdiagnosed and less than 12% of people with FH in the UK are aware that they have this potentially life-threatening condition.
The current recommended screening techniques are costly and time consuming, limiting the number of individuals who benefit from a timely diagnosis. Under NHS guidelines, when a person is found to have FH, their closest blood relatives should get tested too – including children before the age of 10. The new test allows definitive diagnosis within one day, rather than the usual weeks or even months for current tests, removing unnecessary anxiety and allowing people to take immediate action before it’s too late.
The new molecular test that has been developed by Randox Laboratories in Crumlin, Northern Ireland, in partnership with the Belfast Health and Social Care Trust, enables detection of the 40 most common genetic mutations that cause FH in the UK, with results available in just three hours. With early and appropriate treatment, such as adopting a healthy lifestyle and taking cholesterol-lowering medication, risk of heart disease can be significantly reduced so that someone with FH can live as long as a person who doesn’t have the condition.
Professor John Chapman, Past- President of the European Atherosclerosis Society, which promotes study into the causes of accelerated atherosclerosis and cardiovascular disease, has welcomed the new test for suspected cases of FH:
“FH is a serious condition for those with a family history of accelerated atherosclerosis and premature cardiovascular disease. With this information, preventative measures including diet, lifestyle and lipid lowering drugs can be successfully introduced. Indeed, early identification and prevention can significantly benefit all family members potentially with this condition. In fact, we are entering an exciting time in the treatment of those with cardiovascular disease as new and highly effective drugs for lipid management are becoming available.”
The test, which is available through Randox Health Clinics, has been adopted by medical professionals within the NHS, including Dr. Colin Graham, recently retired Consultant Clinical Scientist and former Head of the Regional Genetics Lab in the Belfast Health and Social Care Trust, who introduced the test within his Belfast Laboratory screen for suspected cases of FH:
“The launch of this new clinically available test is a key milestone in the detection and diagnosis of FH. Current FH diagnostic tests require a large volume of samples to be batched, leading to lengthy turnaround times of two to three months. With the new test, the turnaround time is dramatically reduced, enabling more rapid patient diagnosis.”
Dr. Graham also highlighted the importance of improving detection rates through the screening of wider patient populations:
“This new test has the potential to enable FH screening to become routine in the clinical setting for improved detection and earlier identification of familial cases.”
Dr. Peter FitzGerald, Managing Director of Randox Laboratories said:
“In the battle against cardiovascular disease, people with FH are on the front line. On World Heart Day it is important to raise awareness of FH as many people do not even know that they and their family members have this life-threatening condition. There is so much that can be done to support families with FH and with this readily available and much-needed test, detecting and treating entire families with FH is now possible.”
For more information please contact our Randox Comms Team:
Tel: 028 9445 1016
Global biotechnology firm Randox, has invested more than £400,000 in upgrading the telecoms infrastructure near its headquarters in Crumlin, County Antrim. As a result, a number of businesses and residents in Northern Ireland will have access to previously unavailable fibre-optic broadband. The upgrade, essential to supporting Randox’s growing IT requirements, has involved laying down 12 kilometres of fibre-optic cable, stretching from Nutts Corner to the Lough Neagh shoreline.
The telecoms project is part of a wider investment in software, telecoms and data processing by the medical diagnostics company, as IT Manager Stephen Fawl explains:
“Randox is an international company, dealing with customers in more than 145 countries, and as such we need a world class communications network. This new fibreoptic broadband gives us the capacity, security and speed that we need. The new network extending from Nutts Corner to Randox headquarters runs at a hefty 20 gigabytes…That is enough capacity for 15 business parks or a quarter of a million homes.”
Thomas Burns, SDLP Councillor for Aldergrove and Crumlin is encouraging local residents and business owners to take advantage of the improved connectivity:
“The investment by Randox, means that anyone in proximity to the new cable can tap into the highest broadband speeds available. Businesses, especially those depending on electronic orders and skype communications can now expect the same speed and security of internet enjoyed by those in Belfast. Residents in the area can also upgrade through their broadband provider. Before this upgrade project, much of the surrounding area was a telecoms dead zone; but now this is a win-win situation with a significant boost for the local community.”
Residents and business owners in the Crumlin area keen to upgrade to high-speed fibre-optic broadband should contact their internet service provider to discuss various upgrade bundles.
Global biotechnology firm, Randox Laboratories, is taking a leading role in the world’s largest medical conference which is currently under way in Atlanta, Georgia.
The Northern Ireland medical diagnostics company is a major sponsor of the American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, which is attended by over 20,000 delegates and 784 exhibitors from across the globe.
As the leading event for laboratory medicine worldwide, the conference provides an opportunity for breakthrough innovations in clinical testing and patient care to be introduced to the healthcare world.
A group of 32 members of Randox staff are attending the event, exhibiting Randox’s wide range of products and capabilities, which are exported to 145 countries. AACC provides a valuable opportunity to develop new business and clinical partnerships, as well as to consolidate and strengthen current relationships.
Managing Director of Randox, Dr. Peter FitzGerald, is attending the conference and says that the company is proud to be promoting Northern Ireland business to an international audience:
“The global laboratory diagnostics market, is currently valued at around US$55 billion, and is growing at 5.3% per year. With ambitious plans for growth over the next few years, we are committed to improving healthcare worldwide through our investment in our people and the world’s most revolutionary diagnostic technology. Our presence at the AACC annual meeting is fundamental to achieving our strategic aims in promoting our brand, and in strengthening Northern Ireland trade links across the world.”
AACC runs from the 28th – 30th July at the Georgia World Congress Center in Atlanta, Georgia.